MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO)
Historical Holders from Q4 2024 to Q3 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Symbol
-
MBIO on Nasdaq
-
Shares outstanding
-
6,715,538
-
Price per share
-
$1.30
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
280,604
-
Total reported value
-
$426,517
-
% of total 13F portfolios
-
0%
-
Share change
-
+206,342
-
Value change
-
+$329,483
-
Number of holders
-
19
-
Price from insider filings
-
$1.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
Fortress Biotech, Inc.
|
8%
|
+100%
|
$698,416
|
+$361,900
|
537,243
|
+108%
|
Fortress Biotech, Inc.
|
02 Jan 2026
|
|
INTRACOASTAL CAPITAL, LLC
|
5%
|
-42%
|
$491,647
|
-$134,951
|
185,527
|
-22%
|
Mitchell P. Kopin
|
30 Jun 2025
|
|
ARMISTICE CAPITAL, LLC
|
5%
|
-50%
|
$149,887
|
-$5,773,406
|
129,213
|
-97%
|
Armistice Capital, LLC
|
31 Mar 2025
|
As of 30 Sep 2025,
MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) has
19
institutional shareholders
filing 13F forms.
They hold
280,604 shares.
of 6,715,538
outstanding shares (4.2%)
.
Institutional Holders of MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
280,604
|
$426,517
|
+$329,483
|
|
|
$1.52
|
19
|
|
2025 Q2
|
74,262
|
$70,926
|
-$51,419
|
|
|
$0.96
|
16
|
|
2025 Q1
|
113,859
|
$142,327
|
+$142,173
|
|
|
$1.25
|
15
|
|
2024 Q4
|
114
|
$20
|
|
|
|
$0.18
|
1
|